Literature DB >> 29581563

A review of probiotic supplementation in healthy adults: helpful or hype?

Saman Khalesi1, Nick Bellissimo2, Corneel Vandelanotte3, Susan Williams3, Dragana Stanley4, Christopher Irwin5.   

Abstract

Probiotic supplements have a positive impact on several health outcomes. However, the majority of published studies have focused on populations with specific health pathologies. Therefore, this study reviewed the current literature on the health effects of probiotic consumption in "healthy adults." The findings from this review may help guide consumers, researchers, and manufacturers regarding probiotic supplementation. Relevant literature published between 1990 and August 2017 was reviewed. Studies were included if they were experimental trials, included healthy adults, used live bacteria, and had accessible full-text articles published in English. Included studies were classified according to common foci that emerged. Forty-five studies were included in this review. Five foci emerged: gut microbiota changes (n = 15); immune system response (n = 16); lipid profile and cardiovascular disease risk (n = 14); gastrointestinal discomfort (n = 11); and female reproductive health (n = 4). Results suggest that probiotic supplementation in healthy adults can lead to transient improvement in gut microbiota concentration of supplement-specific bacteria. Evidence also supports the role of probiotics in improving immune system responses, stool consistency, bowel movement, and vaginal lactobacilli concentration. There is insufficient evidence to support the role of probiotics to improve blood lipid profile. Probiotic consumption can improve in the immune, gastrointestinal, and female reproductive health systems in healthy adults. However, this review failed to support the ability of probiotics to cause persistent changes in gut microbiota, or improve lipid profile in healthy adults. The feasibility of probiotics consumption to provide benefits in healthy adults requires further investigation.

Entities:  

Mesh:

Year:  2018        PMID: 29581563     DOI: 10.1038/s41430-018-0135-9

Source DB:  PubMed          Journal:  Eur J Clin Nutr        ISSN: 0954-3007            Impact factor:   4.016


  41 in total

Review 1.  Probiotics in the next-generation sequencing era.

Authors:  Jotham Suez; Niv Zmora; Eran Elinav
Journal:  Gut Microbes       Date:  2019-04-05

2.  Ecological Importance of Cross-Feeding of the Intermediate Metabolite 1,2-Propanediol between Bacterial Gut Symbionts.

Authors:  Christopher C Cheng; Rebbeca M Duar; Xiaoxi Lin; Maria Elisa Perez-Munoz; Stephanie Tollenaar; Jee-Hwan Oh; Jan-Peter van Pijkeren; Fuyong Li; Douwe van Sinderen; Michael G Gänzle; Jens Walter
Journal:  Appl Environ Microbiol       Date:  2020-05-19       Impact factor: 4.792

Review 3.  Nutraceuticals as modulators of gut microbiota: Role in therapy.

Authors:  Eamonn M M Quigley
Journal:  Br J Pharmacol       Date:  2020-01-03       Impact factor: 8.739

Review 4.  Finding intestinal fortitude: Integrating the microbiome into a holistic view of depression mechanisms, treatment, and resilience.

Authors:  M C Flux; Christopher A Lowry
Journal:  Neurobiol Dis       Date:  2019-08-24       Impact factor: 5.996

Review 5.  Timescales of gut microbiome dynamics.

Authors:  Brandon H Schlomann; Raghuveer Parthasarathy
Journal:  Curr Opin Microbiol       Date:  2019-11-02       Impact factor: 7.934

Review 6.  The seminal microbiome in health and disease.

Authors:  Jason M Franasiak; Reet Mändar; Signe Altmäe
Journal:  Nat Rev Urol       Date:  2019-11-15       Impact factor: 14.432

Review 7.  Outlook on next-generation probiotics from the human gut.

Authors:  Francesca De Filippis; Alessia Esposito; Danilo Ercolini
Journal:  Cell Mol Life Sci       Date:  2022-01-19       Impact factor: 9.261

8.  Effect of Lactobacillus helveticus CD6 on serum lipid profile and indicators of liver function in high-fat diet fed Swiss albino mice.

Authors:  Mahesh P Patil; Jayesh J Ahire; Ulhas K Patil; Bharat Bhushan; Bhushan L Chaudhari
Journal:  3 Biotech       Date:  2021-05-15       Impact factor: 2.893

Review 9.  Gut microbes in cardiovascular diseases and their potential therapeutic applications.

Authors:  Ling Jin; Xiaoming Shi; Jing Yang; Yangyu Zhao; Lixiang Xue; Li Xu; Jun Cai
Journal:  Protein Cell       Date:  2020-09-28       Impact factor: 14.870

Review 10.  Gut Microbiota: Critical Controller and Intervention Target in Brain Aging and Cognitive Impairment.

Authors:  Hui Li; Junjun Ni; Hong Qing
Journal:  Front Aging Neurosci       Date:  2021-06-25       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.